Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (QutenzaTM) in diabetic neuropathic pain patients: detection of distinct response groups
Christian Martini1,*, Ashraf Yassen2,*, Erik Olofsen1, Paul Passier2, Malcom Stoker3, Albert Dahan1 1Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands; 2Global Clinical Pharmacology and Exploratory Development, Astellas Pharma Global Development Europe, Leiderdo...
Main Authors: | Martini C, Yassen A, Olofsen E, Passier P, Stoker M, Dahan A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Journal of Pain Research |
Online Access: | http://www.dovepress.com/pharmacodynamic-analysis-of-the-analgesic-effect-of-capsaicin-8-patch--a9496 |
Similar Items
-
Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain
by: Peppin JF, et al.
Published: (2011-11-01) -
A review of the high-concentration capsaicin patch and experience in its use in the management of neuropathic pain
by: Ganesan Baranidharan, et al.
Published: (2013-09-01) -
Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
by: Colette Mankowski, et al.
Published: (2016-01-01) -
Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
by: Colette Mankowski, et al.
Published: (2017-04-01) -
Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability
by: Laklouk M, et al.
Published: (2016-09-01)